Atul Dandekar, CSBO at Maze Therapeutics, Inc. (MAZE), sold 7,500 shares at $29.26 ($220K) on 2026-03-30, disclosed to the SEC on 2026-04-01.
Scheduled sale ($220k) by CSBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.26 | 6,710 | $196K | 89.2% |
| 2 | $30.02 | 790 | $24K | 10.8% |
| Total | $29.34 avg | 7,500 | $220K | 100% |
| Filing → |
| MAZE | SELL | 2026-08-31 | $207K | — | Filing → |
| MAZE | SELL | 2026-07-31 | $205K | — | Filing → |
| MAZE | SELL | 2026-07-01 | $210K | — | Filing → |